What is C-dat?
C-dat operates as a specialized provider of critical diagnostic and verification services, including Paternity DNA Testing, Immigration DNA Testing, Live Scan Fingerprinting, and Consortium DOT Drug and Alcohol Testing. With nearly a decade of industry experience, the company has established a strong market presence in the San Francisco Bay Area and beyond. Their business model centers on providing affordable, confidential, and highly accurate testing solutions that cater to both individual needs and corporate compliance requirements. By maintaining rigorous standards in laboratory testing and biometric data collection, C-dat serves as a vital partner for employers navigating regulatory landscapes and families requiring verified biological documentation.
How much funding has C-dat raised?
C-dat has raised a total of $40K across 1 funding round:
Debt
$40K
Debt (2021): $40K with participation from PPP
Key Investors in C-dat
PPP
Public-Private Partnership
What's next for C-dat?
With the infusion of this recent capital, C-dat is poised to accelerate its strategic roadmap, focusing on the expansion of its testing infrastructure and the optimization of its digital service platforms. The company aims to deepen its penetration in the corporate health and compliance market, where demand for reliable DOT drug and alcohol testing remains high. Furthermore, the firm is expected to invest in advanced diagnostic technologies to maintain its competitive edge in the DNA testing space. As the regulatory environment for immigration and workplace safety continues to evolve, C-dat is strategically positioned to capture additional market share by emphasizing its commitment to professional integrity and operational efficiency.
See full C-dat company page
